326 related articles for article (PubMed ID: 27186591)
1. Idebenone for Leber's hereditary optic neuropathy.
Gueven N
Drugs Today (Barc); 2016 Mar; 52(3):173-81. PubMed ID: 27186591
[TBL] [Abstract][Full Text] [Related]
2. Idebenone: A Review in Leber's Hereditary Optic Neuropathy.
Lyseng-Williamson KA
Drugs; 2016 May; 76(7):805-13. PubMed ID: 27071925
[TBL] [Abstract][Full Text] [Related]
3. Visual function in chronic Leber's hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset.
Pemp B; Kircher K; Reitner A
Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2751-2757. PubMed ID: 31482278
[TBL] [Abstract][Full Text] [Related]
4. A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy.
Klopstock T; Yu-Wai-Man P; Dimitriadis K; Rouleau J; Heck S; Bailie M; Atawan A; Chattopadhyay S; Schubert M; Garip A; Kernt M; Petraki D; Rummey C; Leinonen M; Metz G; Griffiths PG; Meier T; Chinnery PF
Brain; 2011 Sep; 134(Pt 9):2677-86. PubMed ID: 21788663
[TBL] [Abstract][Full Text] [Related]
5. Idebenone protects against retinal damage and loss of vision in a mouse model of Leber's hereditary optic neuropathy.
Heitz FD; Erb M; Anklin C; Robay D; Pernet V; Gueven N
PLoS One; 2012; 7(9):e45182. PubMed ID: 23028832
[TBL] [Abstract][Full Text] [Related]
6. Novel use of idebenone in Leber's hereditary optic neuropathy in Hong Kong.
Cheng SW; Ko CH; Yau SK; Mak C; Yuen YF; Lee CY
Hong Kong Med J; 2014 Oct; 20(5):451-4. PubMed ID: 25307075
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Japanese patients with Leber's hereditary optic neuropathy and idebenone trial: a prospective, interventional, non-comparative study.
Ishikawa H; Masuda Y; Ishikawa H; Shikisima K; Goseki T; Kezuka T; Terao M; Miyazaki A; Matsumoto K; Nishikawa H; Gomi F; Mimura O
Jpn J Ophthalmol; 2021 Jan; 65(1):133-142. PubMed ID: 33185792
[TBL] [Abstract][Full Text] [Related]
8. [Response to idebenone and multivitamin therapy in Leber's hereditary optic neuropathy].
Barnils N; Mesa E; Muñoz S; Ferrer-Artola A; Arruga J
Arch Soc Esp Oftalmol; 2007 Jun; 82(6):377-80. PubMed ID: 17573650
[TBL] [Abstract][Full Text] [Related]
9. [Raxone in the Leber optical neuropathy: Parisian experience].
Orssaud C; Bidot S; Lamirel C; Brémond Gignac D; Touitou V; Vignal C
J Fr Ophtalmol; 2019 Mar; 42(3):269-275. PubMed ID: 30712826
[TBL] [Abstract][Full Text] [Related]
10. Altering neuronal circuitry with 4-aminopyridine for visual improvement in Leber's hereditary optic neuropathy (LHON).
Chan JW; Sultan W; Karanjia R; Sadun AA
Mitochondrion; 2022 Jan; 62():181-186. PubMed ID: 34915201
[TBL] [Abstract][Full Text] [Related]
11. Idebenone treatment in Leber's hereditary optic neuropathy.
Carelli V; La Morgia C; Valentino ML; Rizzo G; Carbonelli M; De Negri AM; Sadun F; Carta A; Guerriero S; Simonelli F; Sadun AA; Aggarwal D; Liguori R; Avoni P; Baruzzi A; Zeviani M; Montagna P; Barboni P
Brain; 2011 Sep; 134(Pt 9):e188. PubMed ID: 21810891
[No Abstract] [Full Text] [Related]
12. Idebenone in Friedreich ataxia and Leber's hereditary optic neuropathy: close mechanisms, similar therapy?
Schiff M; Rustin P
Brain; 2016 Jul; 139(Pt 7):e39. PubMed ID: 27095078
[No Abstract] [Full Text] [Related]
13. Leber's hereditary optic neuropathy: course of disease in consideration of idebenone treatment and type of mutation.
Tonagel F; Wilhelm H; Richter P; Kelbsch C
Graefes Arch Clin Exp Ophthalmol; 2021 Apr; 259(4):1009-1013. PubMed ID: 33337510
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial.
Yu-Wai-Man P; Carelli V; Newman NJ; Silva MJ; Linden A; Van Stavern G; Szaflik JP; Banik R; Lubiński W; Pemp B; Liao YJ; Subramanian PS; Misiuk-Hojło M; Newman S; Castillo L; Kocięcki J; Levin MH; Muñoz-Negrete FJ; Yagan A; Cherninkova S; Katz D; Meunier A; Votruba M; Korwin M; Dziedziak J; Jurkutė N; Harvey JP; La Morgia C; Priglinger C; Llòria X; Tomasso L; Klopstock T;
Cell Rep Med; 2024 Mar; 5(3):101437. PubMed ID: 38428428
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants affecting NQO1 protein levels impact the efficacy of idebenone treatment in Leber hereditary optic neuropathy.
Aleo SJ; Del Dotto V; Romagnoli M; Fiorini C; Capirossi G; Peron C; Maresca A; Caporali L; Capristo M; Tropeano CV; Zanna C; Ross-Cisneros FN; Sadun AA; Pignataro MG; Giordano C; Fasano C; Cavaliere A; Porcelli AM; Tioli G; Musiani F; Catania A; Lamperti C; Marzoli SB; De Negri A; Cascavilla ML; Battista M; Barboni P; Carbonelli M; Amore G; La Morgia C; Smirnov D; Vasilescu C; Farzeen A; Blickhaeuser B; Prokisch H; Priglinger C; Livonius B; Catarino CB; Klopstock T; Tiranti V; Carelli V; Ghelli AM
Cell Rep Med; 2024 Feb; 5(2):101383. PubMed ID: 38272025
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of treatment with idebenone in Leber's hereditary optic neuropathy in the Netherlands: A national cohort study.
van Everdingen JAM; Pott JWR; Bauer NJC; Krijnen AM; Lushchyk T; Wubbels RJ
Acta Ophthalmol; 2022 Sep; 100(6):700-706. PubMed ID: 35394113
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Effects of Idebenone on Leber Hereditary Optic Neuropathy.
Zhao X; Zhang Y; Lu L; Yang H
Curr Eye Res; 2020 Oct; 45(10):1315-1323. PubMed ID: 32111141
[No Abstract] [Full Text] [Related]
18. Idebenone (Raxone°) and Leber hereditary optic neuropathy.
Prescrire Int; 2017 Feb; 26(179):41. PubMed ID: 30726629
[No Abstract] [Full Text] [Related]
19. International Consensus Statement on the Clinical and Therapeutic Management of Leber Hereditary Optic Neuropathy.
Carelli V; Carbonelli M; de Coo IF; Kawasaki A; Klopstock T; Lagrèze WA; La Morgia C; Newman NJ; Orssaud C; Pott JWR; Sadun AA; van Everdingen J; Vignal-Clermont C; Votruba M; Yu-Wai-Man P; Barboni P
J Neuroophthalmol; 2017 Dec; 37(4):371-381. PubMed ID: 28991104
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
